Showing 20,601 - 20,620 results of 44,127 for search '(( 50 ((n decrease) OR (a decrease)) ) OR ( 5 ((nn decrease) OR (mean decrease)) ))', query time: 0.79s Refine Results
  1. 20601

    Data_Sheet_1_The Effects of a 6-Week Controlled, Hypocaloric Ketogenic Diet, With and Without Exogenous Ketone Salts, on Body Composition Responses.pdf by Alex Buga (10361168)

    Published 2021
    “…In a double-blind manner, subjects were randomly assigned to receive ~24 g/day of a racemic BHB-salt (KD + KS; n = 12) or placebo (KD + PL; n = 13). …”
  2. 20602
  3. 20603
  4. 20604
  5. 20605
  6. 20606

    Descriptive statistics. by Mumbi E. Kimani (18692933)

    Published 2024
    “…In Wave 1, counties with larger percentages of Black, Hispanic, American Indian and Alaska Native (AIAN), and Asian American and Pacific Islander (AAPI) residents experienced a greater risk of deaths per 100,000 residents of +22.82 (95% CI 15.09, 30.56), +7.50 (95% CI 1.74, 13.26), +13.52 (95% CI 8.07, 18.98), and +5.02 (95% CI 0.92, 9.12), respectively, relative to counties with larger White populations. …”
  7. 20607

    Definition and description of variables. by Mumbi E. Kimani (18692933)

    Published 2024
    “…In Wave 1, counties with larger percentages of Black, Hispanic, American Indian and Alaska Native (AIAN), and Asian American and Pacific Islander (AAPI) residents experienced a greater risk of deaths per 100,000 residents of +22.82 (95% CI 15.09, 30.56), +7.50 (95% CI 1.74, 13.26), +13.52 (95% CI 8.07, 18.98), and +5.02 (95% CI 0.92, 9.12), respectively, relative to counties with larger White populations. …”
  8. 20608

    COVID-19 deaths count. by Mumbi E. Kimani (18692933)

    Published 2024
    “…In Wave 1, counties with larger percentages of Black, Hispanic, American Indian and Alaska Native (AIAN), and Asian American and Pacific Islander (AAPI) residents experienced a greater risk of deaths per 100,000 residents of +22.82 (95% CI 15.09, 30.56), +7.50 (95% CI 1.74, 13.26), +13.52 (95% CI 8.07, 18.98), and +5.02 (95% CI 0.92, 9.12), respectively, relative to counties with larger White populations. …”
  9. 20609
  10. 20610

    <b>Efficacy and safety of mazdutide in Chinese patients with type 2 diabetes: A </b><b>randomized, double-blind, placebo-controlled phase 2 trial</b> by Bo Zhang (6559)

    Published 2023
    “…RESEARCH DESIGN AND METHODS Adults with type 2 diabetes inadequately controlled with diet and exercise alone or with stable metformin (glycated haemoglobin A1c [HbA1c] of 7.0%–10.5% [53–91 mmol/mol]) were randomized to receive mazdutide 3 mg (n = 51), mazdutide 4.5 mg (n = 49), mazdutide 6 mg (n = 49), open-label dulaglutide 1.5 mg (n = 50) or placebo (n = 51) subcutaneously for 20 weeks. …”
  11. 20611

    Data_Sheet_1_Mediterranean Diet Combined With a Low-Carbohydrate Dietary Pattern in the Treatment of Overweight Polycystic Ovary Syndrome Patients.xlsx by Shanshan Mei (8432559)

    Published 2022
    “…In addition, FPG (0.05 ± 0.38 mmol/mL vs -0.50 ± 1.01 mmol/mL, P < 0.001), FINS (−4.88 ± 6.11 μU/mL vs −8.53 ± 5.61 μU/mL, P < 0.01), HOMA-IR index (−1.11 ± 1.51 vs −2.23 ± 0.25, P < 0.05), and QUIKI index (0.014 ± 0.016 vs 0.028 ± 0.019, P < 0.05) decreased significantly in the MED/LC group compared with the LF group. …”
  12. 20612

    Data_Sheet_2_Mediterranean Diet Combined With a Low-Carbohydrate Dietary Pattern in the Treatment of Overweight Polycystic Ovary Syndrome Patients.xlsx by Shanshan Mei (8432559)

    Published 2022
    “…In addition, FPG (0.05 ± 0.38 mmol/mL vs -0.50 ± 1.01 mmol/mL, P < 0.001), FINS (−4.88 ± 6.11 μU/mL vs −8.53 ± 5.61 μU/mL, P < 0.01), HOMA-IR index (−1.11 ± 1.51 vs −2.23 ± 0.25, P < 0.05), and QUIKI index (0.014 ± 0.016 vs 0.028 ± 0.019, P < 0.05) decreased significantly in the MED/LC group compared with the LF group. …”
  13. 20613
  14. 20614

    Data_Sheet_1_A Multiplex Thyroid-Specific Assay for Quantification of Circulating Thyroid Cell-Free RNA in Plasma of Thyroid Cancer Patients.docx by Samantha Peiling Yang (11328837)

    Published 2021
    “…</p>Conclusion<p>Using a multiplex pre-amplification approach, the TPO cfRNA was a potential biomarker that can track residual thyroid mass. …”
  15. 20615

    The canonical pathway of NF-κB activation is required for TNF-α and IL-1β stimulated eotaxin and MCP-1 gene expression in gingival fibroblasts. by Elisabeth A. Boström (495490)

    Published 2015
    “…<p><b>(A)</b> Time-dependent decrease of IκBα protein in gingival fibroblasts exposed to TNF-α (50 ng/ml) and IL-1β (100 pg/ml) cultured for 5, 10, 15 and 30 min. …”
  16. 20616

    Efficacy of topical brinzolamide in children with retinal dystrophies by Brittni A. Scruggs (511698)

    Published 2019
    “…For treated patients, average visual acuity (LogMAR) ± standard error of the mean improved from 0.5 ± 0.04 pre-treatment to 0.3 ± 0.1 at the second endpoint, 50.2 ± 7.3 months after treatment initiation.…”
  17. 20617
  18. 20618
  19. 20619
  20. 20620